PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases

• Main Authors: Ke Zhang (Author), Xiangyi Kong (Author), Yuan Li (Author), Zhongzhao Wang (Author), Lin Zhang (Author), Lixue Xuan (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Autoimmune diseases and malignant tumors are the two hotspots and difficulties that are currently being studied and concerned by the medical field. The use of PD-1/PD-L1 inhibitors improves the prognosis of advanced tumors, but excessive immune responses can also induce immune-related adverse events...